Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 5.22 USD 5.24% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Maravai LifeSciences Holdings Inc?
Write Note

Maravai LifeSciences Holdings Inc
Other Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maravai LifeSciences Holdings Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Other Items
-$56.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Other Items
-$4.9B
CAGR 3-Years
-46%
CAGR 5-Years
-39%
CAGR 10-Years
8%
Danaher Corp
NYSE:DHR
Other Items
-$6B
CAGR 3-Years
19%
CAGR 5-Years
-62%
CAGR 10-Years
-30%
Mettler-Toledo International Inc
NYSE:MTD
Other Items
-$8.9m
CAGR 3-Years
63%
CAGR 5-Years
-23%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Other Items
$25m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Other Items
-$729m
CAGR 3-Years
12%
CAGR 5-Years
-8%
CAGR 10-Years
-24%
No Stocks Found

Maravai LifeSciences Holdings Inc
Glance View

Market Cap
1.3B USD
Industry
Life Sciences Tools & Services

Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 470 full-time employees. The company went IPO on 2020-11-20. The firm provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The firm's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The company also provides research products for labeling and detecting proteins in cells and tissue samples. Its products include CleanCap, messenger ribonucleic acid (mRNA) and oligonucleotide. The Biologics Safety Testing focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing spectrum. The firm provides ultra-pure nucleotides to customers in the diagnostics, pharma, genomics and research markets.

MRVI Intrinsic Value
3.79 USD
Overvaluation 27%
Intrinsic Value
Price

See Also

What is Maravai LifeSciences Holdings Inc's Other Items?
Other Items
-56.8m USD

Based on the financial report for Dec 31, 2023, Maravai LifeSciences Holdings Inc's Other Items amounts to -56.8m USD.

What is Maravai LifeSciences Holdings Inc's Other Items growth rate?
Other Items CAGR 1Y
77%

Over the last year, the Other Items growth was 77%.

Back to Top